SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
lime
Lv1
1
40 积分
2023-09-07 加入
最近求助
最近应助
互助留言
Relationship between Serum Leptin, Lipid Metabolism, HbA1c, and Renal Function in Individuals with Type 2 Diabetes Mellitus and Obesity and in Individuals with Type 2 Diabetes Mellitus without Obesity
5小时前
待确认
Residual cardiovascular risk: When should we treat it?
1个月前
已完结
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
1个月前
已完结
Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study
1个月前
已完结
Association of High-Density Lipoprotein Parameters and Risk of Heart Failure
1个月前
已完结
Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial
1个月前
已完结
Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study
1个月前
已完结
Comparison of coronary atherosclerotic features in response to achieving LDL-C <55 mg/dl between non-diabetic and diabetic patients: insights from the REASSURE-NIRS registry
3个月前
已完结
Management of diabetic dyslipidemia: Navigating the new American and European Guidelines
3个月前
已完结
Residual cardiovascular risk: When should we treat it?
3个月前
已完结
没有进行任何应助
填错了【积分已退回】
1年前
仅为摘要
1年前
缺页,仅有摘要
1年前
标题错误
1年前
速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论